Respiratory Corticosteroid Intranasal Products

  1. Flunisolide
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  2. Beclomethasone dipropionate (Beconase AQ)
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  3. Triamcinolone Acetonide (Nasacort)
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  4. Fluticasone propionate (Flonase)
    Fluticasone propionate & Azelastine (Dymista)
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  5. Mometasone furoate (Nasonex)
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  6. Budesonide (Rhinocort)
    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
  7. Ciclesonide (Omnaris)

    BID in maintenance treatment of Asthma (Alvesco)
    • Low GI absorption and high first-pass metab.
    • Altered prodrug groups


    Indications: Seasonal rhinitis and prevention of reoccurrence of nasal polyps following surgical removal. Use in children is NOT indicated for all products

    MOA: Adrenal corticosteroids with basic glucocorticoid activity and actions---exact mechanism in the nasal tissue is unknown (decreased inflammatory mediators)

    Warning: use Caution in pateints on systemic alternate-day corticosteroid treatment since HPA suprression likelihood my increase---local delivery can reduced the systemic glucocorticoid activity, some weak mineralcorticoid activity

    Metab: primary in liver, highly protein bound with excretion

    localized infections from Candida albicans

    Patient info: contact MD if exposed to chicken pox/measles
Author
Brook
ID
356631
Card Set
Respiratory Corticosteroid Intranasal Products
Description
Updated